Selank

Selank (CAS 129954-34-3) is a synthetic heptapeptide supplied for laboratory and analytical research use only. It is a stabilised analogue of the endogenous immunomodulatory peptide tuftsin, extended with a Pro-Gly-Pro C-terminal sequence, and is closely related to Semax in origin and research context.

Research background

Selank is characterised in the literature as a nootropic and anxiolytic-class research peptide. Reported areas of investigation include modulation of GABAergic signalling, expression of brain-derived neurotrophic factor (BDNF), enkephalin degradation and immune-related gene expression. Investigators typically study it alongside Semax in the context of neuropeptide signalling, stress-response models and comparative peptide pharmacology.

Specifications

• Compound: Selank
• Sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro
• CAS number: 129954-34-3
• Appearance: Lyophilised white powder
• Purity: 99%+ verified by HPLC-MS
• Available size: 10mg
• Presentation: Sealed, tamper-evident vial

Testing and verification

Every batch is independently analysed by a third-party laboratory using HPLC-MS to confirm identity, quantity and purity. Each lot is assigned a unique batch identifier and published with its corresponding Certificate of Analysis on our Lab Results page, so the exact paperwork for the batch you receive can be reviewed before a vial is ever opened.

Handling and storage

Supplied lyophilised for stability in transit. Store the sealed vial cold and protected from light. Standard laboratory handling practices apply.

Research use only. This material is intended strictly for laboratory and analytical research. It is not a medicine, supplement or therapeutic good, and is not for human or veterinary consumption.